Fact CheckerSign in

NCT04046497CompletedPhase 4

Artificial Intelligence to Measure Adherence to Oral Medication

Early-phase Schizophrenia: Practice-based Research to Improve Outcomes (ESPRITO) - Using Artificial Intelligence to Measure Adherence to Oral Medication

Source: ClinicalTrials.gov · Last updated 13 Oct 2026

Brief summary (registry, in English)

The aims of this project is to use an artificial intelligence (AI) smartphone app to provide support for medication adherence by patients with first episode psychosis.

Status (registry)
Completed
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
139 (actual)
First submitted
1 Jul 2019
Start date
20 Nov 2020
Primary completion date
31 Mar 2025
Lead sponsor
Northwell Health
NCT number
NCT04046497

What you commit to

  • Study type: Interventional · Phase 4
  • Participants enrolled: 139
  • From 20 Nov 2020 to the primary completion date, 31 Mar 2025
  • 5 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • none

Who the study is looking for

  • Enrolled in a CSC program
  • Prescribed an oral antipsychotic

Age in the registry: 15 years to 40 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
InterAct
Coordinator of this site? Confirm its status
Grand RapidsUnited StatesUnknown status
Citrus Health
Coordinator of this site? Confirm its status
HialeahUnited StatesUnknown status
InterAct of Michigan
Coordinator of this site? Confirm its status
KalamazooUnited StatesUnknown status
Red Rock
Coordinator of this site? Confirm its status
Oklahoma CityUnited StatesUnknown status
Family and Children's Services
Coordinator of this site? Confirm its status
TulsaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.